Nutrigenomics Market: By Product Type (Reagents, Kits, and Services), Sample Type (Saliva, Buccal Swab, and Blood), By Application (Diabetes, Obesity, Gastrointestinal, Women’s Health, Neurological, and Others), By End User (Online Platform, hospitals, Clinics, and Others), and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Nutrigenomics Market size was valued at USD 463.1 million in 2023 and is poised to grow at a CAGR of 17.3% from 2024 to 2030. The rising incidence of obesity is one of the key market driver projected to boost the nutrigenomics market growth during the forecast period. The significance of nutritious food among preventative measures for malnutrition, multiple cardiovascular diseases, obesity, and related disorders is also anticipated to drive the growth of the nutrigenomics industry. Globally, the increasing cancer incidence rates are predicted to drive market development. A better understanding of the genetic component of both wellness and illness, among effective therapeutic interventions to help with disease diagnosis, are two additional benefits of nutrigenomics.

Furthermore, understanding the molecular interactions between nutrients and the genome is the main goal of nutrigenomics, which aims to know how different nutrients and dietary patterns can impact human health. It is projected that nutrigenomics would strongly care for the newly developed therapeutic techniques. Nutrigenomics services have developed as a result of growth in the genomics research. Thus, it is predicted that the nutrigenomics market will be driven by the rising application of nutrition within the target demographic and several advantages, such as a focus on illness prevention and reducing the indications of aging which subsequently aid in the expansion of the market. Moreover, the rapid acceptance of genomics and personalized medicine, the rising prevalence of lifestyle diseases like obesity and diabetes, rising awareness of preventative healthcare, and different beneficial pricing strategies employed by market players are some of the favourable factors likely to drive the growth of the global nutrigenomics market.

Nutrigenomics Market Key Developments:
  • In June 2023, Xcode initiated a wide-ranging gene nutrition test along with various aspects of nutrients.  
  • In June 2018, 23&Me made a partnership with GlaxoSmithKline to work on new treatments and possible therapies using human genetics as a foundation for exploration.
  • In February 2018, The Global Genetic Project was initiated by 23&Me to enhance understanding of human genetic variety and deliver insights into health concerns that may affect understated populations in genetic research.
  • In June 2017, DNAFit agreed with Vita Mojo to produce the world's most personalized restaurant menu, designed to each customer's DNA.

Nutrigenomics Market Summary

Study Period

2024 - 2030

Base Year

2023

CAGR

17.3%

Largest Market

North America

Fastest Growing Market

N/A
Nutrigenomics Market Dynamics

The rapid advancement of genomic sequencing, omics technology, and the ability to manage the disease as early as possible has executed strong attention on preventive healthcare. In addition, the preventive medical nutrition emphasizes erasing the probability of the origin of the disease. Moreover, the specific field of Metabonomics has appeared to deal with the study of the estimation of metabolic responses based on nutrient deficiency, which is an approach to characterize the metabolic phenotype of individuals and expect their respective interactions with the environment, gut microbiota, and behaviour. It also has a substantial role in personalized nutrition management and disease prevention. Thus, the increasing demand for preventive medicine through personalized nutrition drives the nutrigenomics market growth.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Nutrigenomics Market Segmentation

By Product Type
  • Reagents
  • Kits
  • Services
By Sample Type
  • Saliva
  • Buccal Swab
  • Blood
By Application
  • Diabetes
  • Obesity
  • Gastrointestinal
  • Women’s Health
  • Neurological
  • Others
By End Users
  • Online platforms
  • Hospitals
  • Clinics
  • Others

Frequently Asked Questions

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

The demand for nutrigenomics is expected to rise due to the prevalence of cardiovascular diseases and obesity among the growing population.

North America is expected to provide more business opportunities for the global nutrigenomics testing market in the future

The leading players in the Nutrigenomics Market are Vitagene, Mapmygenome, Gini Health, geneOmbio, Nutrigenomix, 23andMe Inc., DNAfit, GX Sciences Inc., and Xcode Life.

Historic years considered for the market study are 2019 to 2022, 2023 is considered as the base year for market estimation and the forecast presented from 2024 to 2030.

1. Executive Summary
2. Global Nutrigenomics Market Introduction
2.1. Global Nutrigenomics Market Taxonomy
2.2. Global Nutrigenomics Market Definitions
2.2.1. Product Type
2.2.2. Sample Type
2.2.3. Application
3. Global Nutrigenomics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Nutrigenomics Market Dynamic Factors - Impact Analysis
3.6. Global Nutrigenomics Market Competition Landscape
4. Global Nutrigenomics Market Analysis,2019 - 2023 and Forecast, 2024 - 2030
4.1. Market Analysis,2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Nutrigenomics Market, By Product Type, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1. Reagents
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Kits
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Services
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Nutrigenomics Market Forecast, By Sample Type, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.1. Saliva
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Buccal Swab
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Blood
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Global Nutrigenomics Market, By Application, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.1. Diabetes
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Obesity
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Gastrointestinal
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Woman's Health
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Neurological
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Others
7.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.6.3. Market Opportunity Analysis
8. Global Nutrigenomics Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Nutrigenomics Market - Opportunity Analysis Index, By Product Type, Sample Type, Application and Region, 2024 - 2030
9. North America Nutrigenomics MarketAnalysis,2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.1. By Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
9.1.1. Reagents
9.1.2. Kits
9.1.3. Services
9.2. Sample Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Saliva
9.2.2. Buccal Swab
9.2.3. Blood
9.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Diabetes
9.3.2. Obesity
9.3.3. Gastrointestinal
9.3.4. Woman's Health
9.3.5. Neurological
9.3.6. Others
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. USA
9.4.2. Canada
9.5. North America Nutrigenomics Market - Opportunity Analysis Index, By  Product Type, Sample Type, Application, and Country, 2024 - 2030
9.6. North America Nutrigenomics Market Dynamics Trends
10. Europe Nutrigenomics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
10.1. By Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
10.1.1. Reagents
10.1.2. Kits
10.1.3. Services
10.2. Sample Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Saliva
10.2.2. Buccal Swab
10.2.3. Blood
10.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Diabetes
10.3.2. Obesity
10.3.3. Gastrointestinal
10.3.4. Woman's Health
10.3.5. Neurological
10.3.6. Others
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Nutrigenomics Market - Opportunity Analysis Index, By  Product Type, Sample Type, Application, and Country, 2024 - 2030
10.6. Europe Nutrigenomics Market Dynamics Trends
11. Asia-Pacific Nutrigenomics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
11.1. By Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
11.1.1. Reagents
11.1.2. Kits
11.1.3. Services
11.2. Sample Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Saliva
11.2.2. Buccal Swab
11.2.3. Blood
11.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Diabetes
11.3.2. Obesity
11.3.3. Gastrointestinal
11.3.4. Woman's Health
11.3.5. Neurological
11.3.6. Others
11.4. Country Analysis2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Nutrigenomics Market - Opportunity Analysis Index, By  Product Type, Sample Type, Application, and Country, 2024 - 2030
11.6. Asia-Pacific Nutrigenomics Market Dynamics Trends
12. Latin America Nutrigenomics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
12.1. By Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
12.1.1. Reagents
12.1.2. Kits
12.1.3. Services
12.2. Sample Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Saliva
12.2.2. Buccal Swab
12.2.3. Blood
12.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Diabetes
12.3.2. Obesity
12.3.3. Gastrointestinal
12.3.4. Woman's Health
12.3.5. Neurological
12.3.6. Others
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Rest of Latin America
12.5. Latin America Nutrigenomics Market - Opportunity Analysis Index, By  Product Type, Sample Type, Application, and Country, 2024 - 2030
12.6. Latin America Nutrigenomics Market Dynamics Trends
13. Middle East and Africa Nutrigenomics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
13.1. By Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
13.1.1. Reagents
13.1.2. Kits
13.1.3. Services
13.2. Sample Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Saliva
13.2.2. Buccal Swab
13.2.3. Blood
13.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Diabetes
13.3.2. Obesity
13.3.3. Gastrointestinal
13.3.4. Woman's Health
13.3.5. Neurological
13.3.6. Others
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Nutrigenomics Market - Opportunity Analysis Index, By  Product Type, Sample Type, Application, and Country, 2024 - 2030
13.6. MEA Nutrigenomics Market Dynamics Trends
14. Competition Landscape 
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Sample Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. WellGen Inc
14.2.2. Metagenics Inc.
14.2.3. Genomix Nutrition Inc.
14.2.4. Nutrigenomix
14.2.5. NutraGene
14.2.6. XCODE Life Sciences Pvt. Ltd
14.2.7. Cura Integrative Medicine
14.2.8. NutriProCan
14.2.9. GX Sciences, Inc.
14.2.10. Vitl
15. Research Methodology
16. Key Assumptions and Acronyms
  • WellGen Inc
  • Metagenics Inc.
  • Genomix Nutrition Inc.
  • Nutrigenomix
  • NutraGene
  • XCODE Life Sciences Pvt. Ltd
  • Cura Integrative Medicine
  • NutriProCan
  • GX Sciences, Inc.
  • Vitl

Adjacent Markets